HENREFA
Live / Allowed — Publication / registration review complete (as of 16 Mar 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 26 Oct 2025 filing date already counts against anyone who files later.
Record
- Serial number
- 99462928
- Mark type
- Stylized text
- Filed
- 26 Oct 2025
- Published for opposition
- 07 Apr 2026
- Attorney of record
- Nazly Aileen Bayramoglu
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical products for the prevention and treatment of cancer; Medicinal preparations for the treatment of infectious diseases and for use in oncology; Pharmaceutical preparations for cellular therapy for the treatment of cancer, tumors; Biological preparations for the prevention and treatment of cancer; Medicinal preparations for human purposes for the treatment and prevention of cancer; Chemical preparations for pharmaceutical or medical purposes, namely, for tumor; Diagnostic preparations for medical purposes; Diagnostic preparations for medical purposes used by medical laboratories; Pharmaceutical preparations for the treatment and prevention of cancer, tumors; Pharmaceutical preparations for the treatment of pain; Chemical reagents for medical purposes; Pharmaceutical preparations for suppressing tumors; Chemical preparations for pharmaceutical or medical purposes, namely, for treating oncological diseases, namely, liver cancer, rectal cancer, ovarian cancer, peritoneal cancer, fallopian tube cancer, cervical cancer, lung cancer
Owner
- Shanghai Henlius Biotech, Inc., Shanghai, CN
Prosecution history
- 01 Apr 2026 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 11 Mar 2026 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 11 Mar 2026 — ASSIGNED TO EXAMINER
- 26 Oct 2025 — APPLICATION FILING RECEIPT MAILED
- 26 Oct 2025 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 26 Oct 2025 — NEW APPLICATION ENTERED